Remedy Cell
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
kav 23 Haofek, Haifa, 3508401, IsraelWebsite
www.remedycell.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Remedy Cell
Remedy Cell is a clinical stage biopharmaceutical company dedicated to developing innovative, cell-derived therapies for fibrotic diseases, particularly focusing on pulmonary fibrosis. The company utilizes its proprietary Activated Remedy cell Secretome (ARcS) platform to create novel treatments that promote tissue repair and restore organ function. With a team of experienced scientists and clinical experts, Remedy Cell aims to address the urgent unmet needs of patients suffering from conditions like Idiopathic Pulmonary Fibrosis (IPF). Their current clinical program is centered on the development of RC-0315, a therapy designed to degrade fibrosis and enhance lung function.Explore more
Popular SearchesRemedy CellSIC Code 28,283NAICS Code 32,325Show moreRemedy Cell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Remedy Cell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Remedy Cell had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Remedy Cell
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Remedy Cell is spiking on competitors!
Funding: Get notified immidiatlly once Remedy Cell has new funding data
Website visits: Recent activity has been detected on your website
Check if Remedy Cell has recently received funding, and reach out quickly before it becomes old news!
Remedy Cell, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Remedy Cell launches new products
Earning: See what the market has to say on Remedy Cell recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Remedy Cell as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Remedy Cell is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Remedy Cell is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Remedy Cell.
Remedy Cell Tech Stack
A closer look at the technologies used by Remedy Cell
Remedy Cell News & Media
Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved
HAIFA, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its proprietary platform for cell-based solutions through a collaborative network of ventures, today announced expansion of its manufacturing agreement signed in 2024 with Remedy Cell Ltd. (“Remedy Cell”), an innovative biopharmaceutical company developing stem cell-derived, cell-free therapeutics for complex fibrotic conditions.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Remedy Cell
Sign Up For FreeTo access detailed company insights
Remedy Cell is a clinical stage biopharmaceutical company dedicated to developing innovative, cell-derived therapies for fibrotic diseases, particularly focusing on pulmonary fibrosis. The company utilizes its proprietary Activated Remedy cell Secretome (ARcS) platform to create novel treatments that promote tissue repair and restore organ function... Read More
